Recent Company News

• 03:56 AM ET May 28, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (77 total)

• 04:23 AM ET May 27, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (94 total)

• 04:05 AM ET May 13, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (59 total)

• 04:49 AM ET May 12, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:53 AM ET May 12, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (123 total)

• 02:56 AM ET May 12, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:19 AM ET May 12, 2025
  

  Almirall reports Q1 net income €22.1M vs FactSet €17.4M [4 est, €9.9-20.9M] (€9.80, 0.00)

• 10:38 PM ET Mar 27, 2025
  

  Kaken Pharmaceutical notes partner Almirall S.A. receives marketing authorization for Efinaconazole in Italy (¥4520.0000, -68)

• 05:24 AM ET Mar 20, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (75 total)

• 08:19 AM ET Mar 12, 2025
  

  StreetAccount Summary - European unusual volume traders